Search results for "Cardiovascular risk"
Pearls for lowering lipids
New guidelines recommend basing treatment decisions on levels of risk rather than LDL targets.
https://immattersacp.org/archives/2016/07/lipids.htm
1 Jul 2016
MKSAP Quiz: Cardiac risk assessment
A 58-year-old man is evaluated during a routine appointment and asks for advice on cardiac risk assessment. He does not have any current cardiac symptoms, exercises 4 days per week, and has never smoked. He has no chronic health issues and takes no medications. He has no known drug allergies. Results of the physical examination are normal. Following cardiovascular risk calculation, what test should be performed next?
https://immattersacp.org/weekly/archives/2016/04/05/3.htm
5 Apr 2016
Guidance issued on nonstatin therapies for cholesterol lowering
The goal of the decision pathway was to provide practical guidance for clinicians and patients in situations not covered by the 2013 ACC/AHA guideline until new clinical guidelines on the topic are published.
https://immattersacp.org/weekly/archives/2016/04/05/4.htm
5 Apr 2016
Statin treatment reduced cardiovascular events more than hypertension drugs in intermediate-risk patients, study finds
An accompanying editorial said that the results of this trial support the benefits of statins for primary prevention and a risk-based approach to prescribing, rather than one based on LDL levels.
https://immattersacp.org/weekly/archives/2016/04/05/1.htm
5 Apr 2016
There are challenges when translating research to practice
Despite convincing results for many health care interventions, translating evidence from research into clinical practice is often challenging. What works in a research environment may not function in practice.
https://immattersacp.org/archives/2016/04/policy.htm
1 Apr 2016
Shifting standards for hypertension
New hypertension guidelines are being developed by the American Heart Association (AHA) and the American College of Cardiology (ACC) that will incorporate new study results. At issue is how these results apply to the many types of patients who walk through the office door, including those with diabetes.
https://immattersacp.org/archives/2016/03/hypertension.htm
1 Mar 2016
ARBs may offer same efficacy, better tolerability than ACE inhibitors
Meta-regression analysis showed that the difference between angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) compared with placebo was due to a higher placebo event rate in the ACE inhibitor trials for the outcome of all-cause mortality, cardiovascular death, and myocardial infarction.
https://immattersacp.org/weekly/archives/2016/01/12/6.htm
12 Jan 2016
Warning on HCV treatments; more cancer drugs approved
This update also covers a warning that combination drugs can cause serious liver injury and approval of new drugs for metastatic non-small-cell lung cancer that has progressed after other treatments.
https://immattersacp.org/archives/2016/01/fda.htm
1 Jan 2016
Societies stress shared decision making in updated lipids performance measures
Better patient outcomes are realized only if patients agree with, act on, and adhere to their doctors' advice for 5 to 10 years, but up to half of patients stop statins at 1 to 2 years.
https://immattersacp.org/weekly/archives/2015/12/15/5.htm
15 Dec 2015
Shared physician and patient financial incentives associated with most LDL improvement
Participants were randomized to 1 of 4 groups: a control group, a group where physicians could receive up to $1,024 per patient meeting LDL goals, a group where patients could win up to $1,024 in daily lotteries for medication adherence, or a group where the incentives were shared between physicians and patients.
https://immattersacp.org/weekly/archives/2015/11/17/6.htm
17 Nov 2015